Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is down -32.20% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BIO stock a score of 31 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 21. BIO's rank also includes a long-term technical score of 36. BIO has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on BIO!